REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/29/2026
Back to search
Official data from USPTO
AGILEX BIOLABS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AGILEX BIOLABS
ST13
US500000079289957Class
42
Filing
79289957
Registration
6398893
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
06/29/2026
Trademark type
Word
Nice classes
42
Filing date
06/05/2020
Registration date
06/29/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/29/2021
Last transaction
06/29/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
82
Owner location
AU
Examiner
GLASSER, CARYN
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Agilex Biolabs Pty Ltd
Representatives
David L. May Nixon Peabody LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Advisory services relating to biochemistry; advisory services relating to pharmacology; advisory services relating to product testing; advisory services relating to sciencenamely consulting services in the field of bioanalytics; advisory services relating to scientific research; analysis of materialsnamely bioanalytical services; analytical laboratory services; biochemistry research services; biochemistry servicesnamely biochemistry research services; biological research; biotechnological research; biotechnology research; biotechnology testing in the field of bioanalytics; development of testing methods for clinical trials; conducting clinical trials FOR OTHERS; consultancy pertaining to pharmacology; laboratory analysis in the field of bioanalytics; laboratory research relating to bioanalytics; medical research laboratory services; laboratory services being scientific research or analysis; laboratory testing services in the field of bioanalytics; medical research; pharmaceutical research services; preparation of reports relating to scientific research; provision of information relating to scientific research in the field of bioanalytics; product quality testing; research laboratories in the field of bioanalytics; scientific research relating to biotechnology; scientific research relating to medicine; scientific research relating to pharmaceuticals; scientific and technical analysis in the field of bioanalytics; scientific research consultancy in the field of bioanalytics; scientific laboratory services in the field of bioanalytics; scientific research; scientific testing services in the field of bioanalytics; testing services for assessing the efficiency of pharmaceuticals; testing services for assessing the safety of pharmaceuticals; testing of products
Publications
History of USPTO decisions and trademark events.
31 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/15/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/27/2021
FIMP
FINAL DISPOSITION PROCESSED
10/27/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/29/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
06/29/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/13/2021
PUBO
PUBLISHED FOR OPPOSITION
04/13/2021
GPNX
NOTIFICATION PROCESSED BY IB
04/12/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/24/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/24/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/24/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/11/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/05/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/04/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/04/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/19/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/19/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/19/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/19/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/19/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/19/2021
RFNT
REFUSAL PROCESSED BY IB
10/25/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/03/2020
RFRR
REFUSAL PROCESSED BY MPU
10/03/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/16/2020
CNRT
NON-FINAL ACTION WRITTEN
09/15/2020
DOCK
ASSIGNED TO EXAMINER
09/08/2020
MAFR
APPLICATION FILING RECEIPT MAILED
07/28/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/24/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/23/2020
Continuous trademark protection
Get notified about every new filing that threatens AGILEX BIOLABS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.